AI Research
Promising Artificial Intelligence Stocks To Watch Now – September 13th – MarketBeat
AI Research
Lila Sciences raises $235 million to expand AI-driven research platform | Pharmaceutical | The Pharmaletter
Lila Sciences has secured $235 million in series A financing, co-led by Braidwell and Collective Global, at a valuation of about $1.23 billion. The Massachusetts-based company, founded by Flagship Pioneering in 2023, is building an artificial intelligence platform designed to automate and accelerate the scientific method across multiple disciplines.
The latest financing follows a $200-million seed round in March and will be used to hire staff and open new sites in Boston, San Francisco and London. These locations will house the company’s so-called AI Science Factories, facilities that integrate AI, robotics and laboratory systems to design and run experiments at scale. Lila says these factories have already conducted hundreds of thousands of studies across life science, chemistry and materials science.
Building autonomous science at scale
This article is accessible to registered users, to continue reading please register for free. A free trial will give you access to exclusive features, interviews, round-ups and commentary from the sharpest minds in the pharmaceutical and biotechnology space for a week. If you are already a registered user please login. If your trial has come to an end, you can subscribe here.
Try before you buy
Free
7 day trial access
- All the news that moves the needle in pharma and biotech
- Exclusive features, podcasts, interviews, data analyses and commentary from our global network of life sciences reporters.
- Receive The Pharma Letter daily news bulletin, free forever.
Become a subscriber
£820
Or £77 per month
- Unfettered access to industry-leading news, commentary and analysis in pharma and biotech.
- Updates from clinical trials, conferences, M&A, licensing, financing, regulation, patents & legal, executive appointments, commercial strategy and financial results.
- Daily roundup of key events in pharma and biotech.
- Monthly in-depth briefings on Boardroom appointments and M&A news.
- Choose from a cost-effective annual package or a flexible monthly subscription
The Pharma Letter is an extremely useful and valuable Life Sciences service that brings together a daily update on performance people and products. It’s part of the key information for keeping me informed
Chairman, Sanofi Aventis UK
AI Research
Tech war: Tencent pushes adoption of Chinese AI chips as mainland cuts reliance on Nvidia
Tencent has “fully adapted to mainstream domestic chips” and “participates in the open-source community”, Tencent Cloud president Qiu Yuepeng said at the company’s annual Global Digital Ecosystem Summit on Tuesday.
-
Business3 weeks agoThe Guardian view on Trump and the Fed: independence is no substitute for accountability | Editorial
-
Tools & Platforms1 month ago
Building Trust in Military AI Starts with Opening the Black Box – War on the Rocks
-
Ethics & Policy2 months agoSDAIA Supports Saudi Arabia’s Leadership in Shaping Global AI Ethics, Policy, and Research – وكالة الأنباء السعودية
-
Events & Conferences4 months agoJourney to 1000 models: Scaling Instagram’s recommendation system
-
Jobs & Careers3 months agoMumbai-based Perplexity Alternative Has 60k+ Users Without Funding
-
Podcasts & Talks2 months agoHappy 4th of July! 🎆 Made with Veo 3 in Gemini
-
Education3 months agoVEX Robotics launches AI-powered classroom robotics system
-
Education2 months agoMacron says UK and France have duty to tackle illegal migration ‘with humanity, solidarity and firmness’ – UK politics live | Politics
-
Podcasts & Talks2 months agoOpenAI 🤝 @teamganassi
-
Funding & Business3 months agoKayak and Expedia race to build AI travel agents that turn social posts into itineraries